FREE PSA AND CLINICALLY SIGNIFICANT ANDFATAL PROSTATE CANCER IN THE PLCO SCREENING TRIAL

被引：0
|
作者：
Yim, Kendrick
Ma, Chaoran
Carlsson, Sigrid
Lilja, Hans
D'Andrea, Vincent
Mucci, Lorelei
Penney, Kathryn
Preston, Mark
机构：
来源：
JOURNAL OF UROLOGY | 2023年 / 209卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PD38-09
引用
收藏
页码：E996 / E997
页数：2
相关论文
共 50 条
  • [11] Relationship of PSA velocity and Gleason score in the PLCO cancer screening trial
    Grubb, RL
    Levin, DL
    Pinsky, PF
    Mabie, J
    Riley, TL
    Reding, DJ
    Ragard, LR
    Crawford, ED
    Andriole, GL
    JOURNAL OF UROLOGY, 2006, 175 (04): : 169 - 169
  • [12] PSA prostate cancer screening trial
    不详
    PROSTATE CANCER AND PROSTATIC DISEASES, 2001, 4 (01) : 3 - 4
  • [13] The Use of PSA Density as a Predictor of Clinically Significant Prostate Cancer
    MacCormick, A.
    BRITISH JOURNAL OF SURGERY, 2018, 105 : 71 - 72
  • [14] Positive biopsy (bx) rates for prostate cancer (PCA) based on prostate specific antigen (PSA) grouping in a large cancer screening trial: Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO).
    Reding, D.
    McCarty, C.
    Riley, T.
    Hickey, T.
    Hocking, W. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [15] PSA testing interval, reduction in screening intervals: data from the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial
    Crawford, ED
    Chia, D
    Andriole, GL
    Reding, D
    Gelman, EP
    Gohagan, JK
    Pinsky, P
    Hayes, RB
    Levin, DL
    Fagerstrom, RM
    Kramer, BS
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 97 - 97
  • [16] Insights From the PLCO Trial About Prostate Cancer Screening
    Gulati, Roman
    Albertsen, Peter C.
    CANCER, 2017, 123 (04) : 546 - 548
  • [17] USEFULNESS OF FREE PSA RATIO TO ENHANCE DETECTION OF CLINICALLY SIGNIFICANT PROSTATE CANCER IN PATIENTS WITH PIRADS <3 AND PSA ≤10
    Kang, Kevin
    Park, Chang Rae
    Heo, Ji Eun
    Lee, Kwang Suk
    Jang, Won Sik
    Ham, Won Sik
    Han, Woong Kyu
    Kim, Jang Hwan
    Choi, Young Deuk
    Lee, Jongsoo
    Kang, Kevin
    JOURNAL OF UROLOGY, 2024, 211 (05): : E785 - E786
  • [18] Utility of Free/total PSA Ratio to Detect Clinically Significant Prostate Cancer in a Normal Population with Lower PSA Level
    Arai, Yoichi
    Ishidoya, Shigeto
    Ito, Akihiro
    Saito, Seiichi
    TUMOR BIOLOGY, 2008, 29 : 39 - 39
  • [19] INITIAL PSA LEVELS AND PROSTATE CANCER DIAGNOSIS WITH UP TO 7 YEARS FOLLOW-UP IN THE PLCO CANCER SCREENING TRIAL
    Black, Amanda
    Grubb, Robert L.
    Hickey, Thomas
    Pinsky, Paul F.
    Reding, Douglas
    Izmirlian, Grant
    Mabie, Jerome
    Riley, Thomas
    Ragard, Lawrence R.
    Prorok, Philip C.
    Christine, D.
    Crawford, E. David
    Andriole, Gerald L., Jr.
    JOURNAL OF UROLOGY, 2009, 181 (04): : 647 - 647
  • [20] POTENTIAL FOR INCREASE IN SCREENING INTERVAL BASED ON INITIAL PSA: DATA FROM THE PROSTATE, LUNG, COLORECTAL AND OVARIAN (PLCO) CANCER SCREENING TRIAL
    Crawford, E. David
    Black, Amanda
    Grubb, Robert L., III
    Chai, David
    Andriole, Gerald L., Jr.
    Reding, Douglas
    Prorok, Philip C.
    Berg, Christine D.
    Pinsky, Paul F.
    Hayes, Richard B.
    Levin, David L.
    Kramer, Barrett S.
    JOURNAL OF UROLOGY, 2009, 181 (04): : 770 - 770
12345